open access

Vol 6, No 4 (2001)
Published online: 2001-01-01
Submitted: 2001-08-31
Get Citation

Adjuvant treatments for non-small cell lung cancer

Paul Van Houtte, F. Mornex, M. Roelandts
DOI: 10.1016/S1507-1367(01)70971-6
·
Rep Pract Oncol Radiother 2001;6(4):173-179.

open access

Vol 6, No 4 (2001)
Published online: 2001-01-01
Submitted: 2001-08-31

Abstract

Surgery remains the cornerstone for the curative treatment of non-small cell lung cancer (NSCLC). Long-term survival depends on different prognostic factors including the tumour extent (the T and N stage) and the quality of the surgical resection (complete vs. incomplete resection, the type of mediastinal exploration). Nevertheless, only one-third of all operated patients will be metastases alive 5 years after the surgical resection. Failures are due to a loco-regional relapse, distant metastases or a second primary cancer related to the long story of tobacco abuse. The pattern of failure analysis should decide on the type of adjuvant treatment: a loco regional modality or a form of systemic treatment such as chemotherapy or immunotherapy.

Abstract

Surgery remains the cornerstone for the curative treatment of non-small cell lung cancer (NSCLC). Long-term survival depends on different prognostic factors including the tumour extent (the T and N stage) and the quality of the surgical resection (complete vs. incomplete resection, the type of mediastinal exploration). Nevertheless, only one-third of all operated patients will be metastases alive 5 years after the surgical resection. Failures are due to a loco-regional relapse, distant metastases or a second primary cancer related to the long story of tobacco abuse. The pattern of failure analysis should decide on the type of adjuvant treatment: a loco regional modality or a form of systemic treatment such as chemotherapy or immunotherapy.

Get Citation
About this article
Title

Adjuvant treatments for non-small cell lung cancer

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 6, No 4 (2001)

Pages

173-179

Published online

2001-01-01

DOI

10.1016/S1507-1367(01)70971-6

Bibliographic record

Rep Pract Oncol Radiother 2001;6(4):173-179.

Authors

Paul Van Houtte
F. Mornex
M. Roelandts

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl